ID-4708 explained

Drug Name:ID-4708
Width:250px
Cas Number:42048-72-6
Pubchem:198237
Chemspiderid:171579
C:22
H:24
F:4
N:2
O:2
Smiles:C1CN(CCC1(C2=CC(=CC=C2)C(F)(F)F)O)CCCC(=O)C3=C(C=C(C=C3)F)N

ID-4708 is a butyrophenone neuroleptic agent. It has the same structure as for trifluperidol but differs by the incorporation of an aniline amino group into the butyrophenone sidechain.

Whereas trifluperidol is a Belgian drug developed at Janssen Pharmaceuticals, ID-4708 was developed by a Japanese company called Sumitomo Chemical in the 1970’s.

ID-4708 when given at low doses reduced ambulation, while at higher doses defecation was inhibited.[1]

Synthesis

The chemical synthesis of ID-4708 was reported:[2] [3]

Notes and References

  1. Honma T, Kitagawa S . [Effects of minor tranquilizers and neuroleptics on open-field behavior in rats (author's transl)] . Japanese . Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica . 73 . 3 . 337–45 . April 1977 . 21127 . 10.1254/fpj.73.337 .
  2. Honma T, Sasajima K, Ono K, Kitagawa S, Inaba S, Yamamoto H . Synthesis and preliminary pharmacology of a novel butyrophenone derivative, ID-4708 . Arzneimittel-Forschung . 24 . 9 . 1248–56 . September 1974 . 4479786 . 10.1002/chin.197451331 .
  3. Kikuo Sasajima, et al. US4075346 (1978 to Sumitomo Chemical Co Ltd).